OBJECTIVES: Left main disease (LMD), combined with carotid artery stenosis (CAS), constitutes a high-risk patient population. Priority is often given to coronary revascularization, due to the severity of the angina. However, the choice of revascularization strategy [off-pump coronary artery bypass (OPCAB) vs coronary artery bypass grafting (CABG)] remains elusive.
INTRODUCTION
Significant stenosis of the left main disease (LMD), especially in the presence of multivessel disease, represents the most compound form of coronary atherosclerosis and remains a strong indication for revascularization in both symptomatic and asymptomatic patients [1] . Coronary artery bypass grafting (CABG) is reported to offer a significant survival advantage as well as a reduced need for repeated intervention when compared with percutaneous coronary intervention within the LMD. However, the higher incidence of cerebrovascular accidents in surgically treated patients varying from 0.8 to 5.2% casts a shadow on the overall benefit of CABG [2] .
With atherosclerosis being a systemic disease affecting multiple arterial beds within the same patient, the coexistence of severe coronary artery disease (CAD) and carotid artery disease (CAS) is not rare. Recent reports reveal that 8-15% of patients undergoing surgical revascularization have an advanced carotid disease, whereas 28-40% of patients undergoing carotid endarterectomy suffer from CAD [3] . 'Carotid before coronary', a revascularization strategy, has therefore been widely applied with the good results of both procedures with a minimal risk [4] . The situation differs in the left main disease (LMD), combined with severe CAS. While priority is given to coronary revascularization, the most beneficial surgical technique has not been defined. The off-pump coronary artery bypass (OPCAB) grafting technique was introduced to overcome CABG's deficiencies such as aortic cross-clamping and cardiopulmonary bypass, thus minimizing the risk of stroke. However, early indications for OPCAB excluded patients with LMD due to the potential for haemodynamic compromise [5] . A growing experience has enabled this type of surgical coronary revascularization to be safe and effective even in the high-risk patient population [6] .
The aim of this study was to determine whether off-pump coronary revascularization provides better in-hospital and late outcomes in patients with LMD with concomitant carotid stenosis in comparison with the conventional CABG.
MATERIALS AND METHODS

Data sources and study population
All data were collected prospectively between 1 January 2006 and 21 September 2010; 4151 consecutive patients with isolated CADs were operated on at the Silesian Center for Heart Diseases in Zabrze, Poland. Among these, 1340 patients were diagnosed with LMD, both isolated and non-isolated and underwent surgical coronary revascularization with the use of extracorporeal circulation (ECC; CABG group, n = 680) and without it (OPCAB group, n = 634). Patients were non-randomly assigned to the groups, as the surgical technique was chosen on the basis of the surgeon's preference, technical feasibility and associated comorbidities (Table 1) .
To identify whether the extent of the carotid artery disease represents an additional risk of neurological complications, the study population was divided into six groups depending on the severity of the carotid stenosis. Group 1 included patients with unilateral and bilateral stenoses up to 50%, Group 2 patients with unilateral and bilateral stenoses between 50 and 70%, Group 3 unilateral 70-100% occlusion, Group 4 unilateral 70-100% occlusion together with coexisting subcritical (50-70%) disease and Group 5 consisted of patients with bilateral 70-100% carotid occlusion. Patients not screened for CAS were gathered in Group 0. History of previous stroke, transient ischaemic attack (TIA) and surgical or percutaneous interventions within carotid arteries were also analysed ( Table 2) .
Surgical technique
A median sternotomy was performed in all patients. The CABG surgery with the ECC was performed with a uniform approach using ascending aortic cannulation and two-stage venous cannulation. During the ECC, the mean arterial pressure target was set at 60 mmHg and body temperature allowed to drift or was set to a minimum of 32°C. Intermittent cold blood cardioplegia (1:4 blood to crystalloid with a maximal K+ concentration of 22 mEq/l) was delivered antegrade via the aortic root and retrograde in selected patients. OPCAB surgery was performed mostly with the use of a deep pericardial suture placed in the posterior pericardium for retraction followed by placement of a commercially available tissue stabilizer (Medtronic Octopus and Starfish). A single monofilament suture was then applied to the target vessel proximal to the anastomotic site to achieve intermittent haemostasis after arteriotomy and to facilitate the introduction of the intracoronary shunt of a variable diameter. Graft patency was assessed intraoperatively by transluminar flow measurement (MediStim, USA). The transluminar flow ≤15 ml/min and pulsatility index ≥4.0 were the indications for a graft revision.
Statistics
The results are expressed as a mean value ± standard deviation unless otherwise indicated. A statistical analysis comparing two groups was performed with unpaired two-tailed Student's t-test for the means and the Mann-Whitney U-test for continuous data, whereas categorical variables were compared using the χ 2 test. Multivariable regression was used to determine the risk-adjusted impact of a revascularization strategy on a composite in-hospital outcome: myocardial infarction, need for repeated revascularization, reoperation, stroke, intestinal ischaemia, acute renal failure and death (MACCE), and the proportional hazards regression was used to define the variables affecting long-term survival. Alpha was chosen to be equal to 0.05. For any independent predictor odds ratio (OR), 95% confidence limit (CI) when necessary, and probability value are indicated. The actuarial survival curves were obtained with the Kaplan-Meier method.
Variable selection
Preoperative variables included age, sex, smoking and family history, diabetes (defined as HbA1C on admission ≥6.5%), hypertension, obesity (BMI ≥30), renal insufficiency (defined as preoperative serum creatinine ≥200 μmol/l), chronic obstructive pulmonary disease (defined as disease treated with bronchodilators or steroids) and severe peripheral artery disease (defined as claudication equal to or <100 m). A history of CAD included the presence or incidence of congestive heart failure due to ischaemia, unstable angina (defined as rest angina requiring intravenous nitrates until arrival in anaesthetic room) history of recent (<90 days) myocardial infarction, occurrence and reoccurrence of myocardial infarction in the past, prior successful (TIMI3) or failed percutaneous coronary interventions and antiplatelet treatment strategy [Clopidogrel/Acetylsalicylic acid (ASA)]. Preoperative EuroSCORE, functional class as defined by the NYHA classification system, angina class as defined by the Canadian Cardiovascular Society (CCS) angina class and status ( planned status was defined as 3 months from the qualification) and critical preoperative state (defined as the presence of ventricular tachycardia or fibrillation or aborted sudden death, preoperative cardiac massage, preoperative ventilation before anaesthetic room, preoperative inotropes or IABP and/or preoperative acute renal failure). Intraoperative variables included the type of conduit used for revascularization, mean number of grafts performed, extent of atherosclerosis, calcification of the aorta and the number of endarterectomies performed.
Postoperative outcomes considered included perioperative myocardial infarction (diagnosed as serum troponin >99 percentile of URL with haemodynamic instability or with wall motion abnormality on postoperative transthoracic echocardiography), need for coronary intervention and graft revision (either surgically or percutaneously), reoperation for either bleeding, graft dysfunction and any other cardiac cause, low output syndrome (defined as need for either inotropes postoperatively or mechanical support), new onset of atrial fibrillation, supraventricular and ventricular tachyarrhythmia, ventilation time and need for reintubation, incidence of acute respiratory distress syndrome, pneumo and hydrothorax or infection within respiratory tract, brief psychotic disorder, stroke, postoperative requirement for haemodialysis (transient or permanent), intestinal ischaemia, deep sternal wound infection, length of hospital stay and 30-day mortality. The use of blood product was also analysed. The longterm mortality data were obtained using the National Database of the Ministry of the Health. Table 3 portrays the peri-and postoperative results. Patients in whom OPCAB was performed were older, with slightly lower LVEF and more frequent history of a recent myocardial infarction. They were also more likely to be treated with dual antiplatelet therapy (Clopidogrel + ASA). However, patients with more extensive CAD were more likely to undergo on-pump revascularization ( Fig. 1) . A severely calcified aorta was noted in 7.72% of all OPCAB patients vs 4.43% of the patients operated on-pump (P < 0.05) and was one of the reasons why the off-pump approach was chosen. It shifted the graft selection towards arterial grafts (mostly bilateral IMA's) and a no-touch technique (full arterial revascularization 18.6 vs 7.6%; P < 0.01), contributing however, to a significantly lower number of grafts performed in the OPCAB group (mean number of grafts: 3.19 ± 0.82 CABG vs 2.31 ± 0.70 OPCAB; P < 0.01; Fig. 1 ). Coronary endarterectomies were also performed more often in CABG patients rather than in ones who underwent off-pump procedures (5 vs 1.3%; P < 0.01), slightly influencing the number of grafts implanted in CABG patients.
RESULTS
There were no significant differences in the number of periand early postoperative complications between the two patient cohorts, except in the slightly longer ventilation time and the incidence of low output syndrome, which was encountered twice as often in the CABG group. CABG patients were also more prone to bleeding (3.7 vs 2.4%; NS) and subsequent reoperation (5.7 vs 4.6%; NS) followed by an augmented use of the blood products (58.2 vs 44.0%; P < 0.05), mostly packed red blood cells. Thirty-day mortality and MACCE were insignificantly higher in patients in whom CABG was performed. This trend reversed when late mortality was evaluated. Yet, statistical significance was not achieved (Fig. 2) . Preoperative end-stage renal insufficiency (dialysis dependent) and the number of arterial conduits used were found to be technique-independent predictors of MACCE [OR: 17.46; −95% confidence interval (CI): 1.73; +95% CL: 175.90; P = 0.015 and OR: 0.47; −95% CL: 0.27; +95 CL: 0.83; P = 0.009 when one arterial conduit was used and OR: 0.23; −95% CL: 0.09; +95% CL: 0.59; P = 0.002 when two arterial conduits were used]. Moreover, preoperative NYHA class IV also influenced the late outcome (OR: 8.62; −95% CL: 1.81; +95% CL: 40.97; P = 0.007).
Carotid artery stenosis
Patients with an insignificant carotid disease (Groups 1 and 2) were represented equally in both cohorts. With the growing complexity of the atherosclerosis within the carotid vasculature, aortic cannulation and cross-clamp were more frequently ADULT CARDIAC avoided. Patients with severe stenosis or occlusion of both carotid vessels (Group 5) were almost exclusively operated on off-pump (14 vs 3 patients). Group 0, which contains a considerable number of individuals (253 patients, 37.63%) in whom screening towards CAS was not performed, had a similar survival rate as patients with non-significant unilateral CAS (Group 1), reflecting their low-risk profile. Although there were no differences between the two arms in terms of the incidence of periand postoperative stroke or TIA within the six groups, a notable reduction in the stroke rate in OPCAB patients is seen (Table 4) . Despite the low number of patients, the analysis showed that The completeness of coronary revascularization within specific patient lesion subsets. Significant differences in the number of grafts implanted were found in all patients subsets but one (isolated LMD). Patients with more advanced CAD (LM +3) were significantly more often operated on, compared to those who underwent off-pump procedures. patients with a history of ischaemic brain injury had a significantly higher incidence of neurological complications postsurgery, regardless of the technique (Table 5 ). There were no significant differences in terms of long-term mortality between the groups (Fig. 3) . Sixteen patients had a history of carotid intervention (either stent or surgery). In eight patients, intervention was carried out on RICA (four patients were stented, four patients had endarterectomy), while LICA was treated in six patients (four patients were stented, two patients had endarterectomy). Two patients had a history of intervention (stents) within both carotids. All interventions ( percutaneous and surgical) were done well prior to the coronary revascularization (>6 months). Stent reocclusion (70%) was encountered in one patient. There were no peri-and postoperative neurological complications in this subpopulation.
Twenty-six (1.92%) patients were operated on cardiopulmonary bypass on a beating heart without cross-clamping due to a haemodynamic instability encountered either intraoperatively during OPCAB or initially, as a precaution against the abovementioned. This patient cohort was not included in the final analysis (OPCAB vs CABG) as it represents a separate, high-risk patient population [7] . Twenty-two (22 of 26; 84.6%) patients intended such an approach, as a precaution against perioperative haemodynamic instability. Four (4 of 26; 15.4%) patients required an immediate conversion from OPCAB. Nearly half of all these patients were operated on as an emergency. The mean CCS in this group was 3.23 ± 0.8, five patients were on intravenous NTG support (19.23%) and a similar number required mechanical support (IABP). Nine patients had a significant CAS (34.6%), among them six with a significant bilateral disease (23%) and five with a history of stroke (19%). Mean LVEF was 45.12% ± 13.29 and mean EuroSCORE of 6.54 ± 3.15 (seven patients had ES ≥10). Nearly all patients had a diffused multivessel coronary disease besides LM stenosis and received appropriate, complete revascularization. There were no peri-and postoperative myocardial infarction or ischaemia in this difficult patient population, but a low output syndrome was present in every second patient. Although all patients survived the operations, five (19%) died within the 5 following months.
DISCUSSION
The clinical significance of the LMD within the context of diffuse atherosclerotic disease has been debated intensively for the past three decades. Recently updated guidelines on myocardial revascularization favour surgical treatment in all subsets of CAD except single and two-vessel, non-proximal LAD disease [1] . This includes individuals suffering from both isolated and nonisolated LMD in whom benefits of coronary surgery prevail over percutaneous interventions [8, 9] . Although the abovementioned class IA recommendations are true for stable, low-risk patients, surgical revascularization is also strongly advised (IB) in the specific subgroups of higher-risk individuals, including patients with diabetes, renal dysfunction and chronic heart failure [1, 10] . The management of patients with associated CAD and CVD is, however, beyond standardization, as the choice between surgical and percutaneous revascularization should be individualized and assessed by the Heart Team, considering the comorbidities and the clinical presentation. The choice of surgical technique remains, however, dubious. While the off-pump approach is suggested when treating patients with a chronic kidney disease, 
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diminishing the morbidity caused by the ECC [11] , the currently available evidence does not support this finding to be applicable to a broader patient population. Large prospective and observational studies and trials have confirmed the efficacy, safety and high effectiveness of off-pump coronary revascularization in various patient subpopulations. Chu et al. [12] have documented the comparable in-hospital outcomes of 63 047 patients who underwent OPCAB (n = 14 389) and CABG (48 658). Similar conclusions were found by Reston et al. [13] in a meta-analysis looking at short-and mid-term outcomes of both procedures. Early OPCAB experience did, however, exclude patients with LMD due to the potential risk of haemodynamic instability and subsequent myocardial hypoperfusion [5] . The growing surgical experience, together with greater involvement of the anaesthesiologist in the maintenance of the cardiac preload and afterload, allowed for stable, safe and effective coronary revascularization on a beating heart in patients with LMD [14] . In our institution, OPCAB is the preferred method of treatment for CAD. Since 1987, when the first off-pump revascularization was performed, the number of OPCAB procedures has consistently increased. In 2006, it was slightly over 30% of all patients operated on CAD, but in 2010, it exceeded 75%. Therefore, a timeframe of the past 4 years was chosen to reflect not only the most recent experience, but also times when on-pump procedures were performed on an everyday basis. While 23 surgeons participated in this study, most of the cases were performed by a group of eight experienced consultants. Residents have performed 176 (13.1%) procedures, including 57 OPCABs. There were no significant differences in terms of peri-and postoperative morbidity and mortality between the consultants and the residents.
All patients were subjected to preoperative risk assessment using the EuroSCORE. Since the recently introduced SYNTAX Score has been calculated for a small fraction of the analysed population, it has not been taken into consideration. In general, patients operated on using the off-pump technique had a slightly higher EuroSCORE than those in whom the on-pump revascularization was performed (4.68 ± 2.81 vs 4.21 ± 2.68; P < 0.003), placing the majority of patients within the medium-risk range ( predicted mortality of 3%). In the presented material, patients in OPCAB groups had a slightly lower 30-day mortality than predicted, and lower than that observed in the CABG group (2.7 vs 2.8%; P = NS). Thomas et al. [14] find a similar mortality rate in a smaller cohort of OPCAB patients with LMD and even higher EuroSCORE. The comparable results were published by Biancari et al. [6] , who prospectively analysed over 300 high-risk patients scheduled to undergo CABG or OPCAB surgery. Thirty-day mortality in this series was lower in the OPCAB patients (1.9%) and increased along the logistic EuroSCORE (3.2%). Although the SYNTAX LM substudy [2, 15] does not take the operative technique into consideration, we find our CABG population comparable. The mean EuroSCORE was slightly lower (3.9 ± 2.9), but still within the medium-risk range, together with the history of recent myocardial infarction, diabetes and renal dysfunction. However, the OPCAB group presented in our material is distinct in many fields, indicating a different, more complex patient population, with more comorbidities and thus a higher risk. Yet, 1-and 3-year mortality remain similar in both studies, reflecting the potential benefits of the off-pump approach. The abovementioned complexity of the OPCAB population may be the leading cause of the disparities between OPCAB and CABG observed in the long-term mortality in our study.
The problem of incomplete revascularization appears often when OPCAB and CABG are compared [16, 17] . In the presented material, there is also a significant gap between the two groups in terms of the number of grafts. Despite these discrepancies, a perioperative myocardial infarction was observed in nearly the same number of individuals (2.5 vs 2.4% patients; NS). In all of these cases, a coronary angiography was performed, and a subsequent PCI was carried out in 13 and 11 patients in the OPCAB and CABG groups, respectively. Graft dysfunction was found in three and two patients in the OPCAB and CABG groups, respectively. Nevertheless, the previously published evidence concludes that excellent long-term results are obtained when revascularization is complete [17] . Technical difficulties, combined with haemodynamic instability, are often the reason why the surgeons limit themselves to the most diseased vessels, leaving those with a small diameter or with extensive atherosclerosis intact. The extent of endarterectomies performed in CABG patients supports this thesis. The notion of incomplete revascularization was noticed by ROOBY Trial investigators who noted that patients in the off-pump group had worse composite 30-day and 1-year outcomes than their on-pump counterparts [18] . Moreover, graft patency was poorer in the OPCAB group. The authors indicate the incompleteness of revascularization as one of the key reasons for the significantly higher incidence of death from a cardiac cause within 1 year. Yet, the newly published FAME trial documents that the angiographic severity of a coronary stenosis correlates poorly with its ischaemic potential [19] . The current strategy of performing any type of coronary intervention based on the angiographic appearance of a lesion may not be the most effective technique. Instead, measurements of the fractional flow reserve (FFR) should be performed for the detection of ischaemia-related lesions, when objective evidence of vessel-related ischaemia is not available. This way, a complete 'functional' revascularization, either by PCI or CABG could follow. One-year results of the FAME study reveal a 5.3% difference in the MACE-free survival rate between the population treated with PCI based on an angiographic and FFR evaluation indicating that the routine measurement of FFR in patients with a complex CAD reduces mortality and makes stent placement more efficient and more cost-effective. Although a similar evaluation with surgical revascularization has not yet been undertaken, it makes one wonder if 'complete revascularization' indeed means 'appropriate revascularization'.
Stroke development is a major concern in patients undergoing CABG [20] . Our previously published paper showed that patients with the left main stenosis with prior stroke and/or cerebrovascular disease grafted without CPB did not differ from those grafted with the CPB on early observation with regard to neurological complications despite the fact that a high number of patients qualifying for the OPCAB operation were at high risk of neurological complications [21] . This study confirms this notion, analysing not only composite the in-hospital outcome in a larger cohort, but also the long-term mortality and morbidity associated with CAS.
A history of stroke, together with carotid artery disease and advanced atherosclerosis of the aorta remain the most important preoperative risk factor for postoperative stroke [22] . In a recently published meta-analysis of non-randomized nine studies on 4411 patients with LMD of whom 1036 (23.5%) underwent OPCAB, the authors conclude that the off-pump approach may offer a neurological benefit, as a significantly lower stroke rate was observed in this population [23] . Moreover, early mortality, length of hospital stay, blood loss and inotropic requirements were significantly favoured by OPCAB surgery. Similar findings were noted by Murzi et al. [24] , where 2375 consecutive patients with LMD were operated on using off-and on-pump techniques. Again, OPCAB was associated with lower in-hospital mortality, incidence of stroke, postoperative renal dysfunction, pulmonary and infectious complications. In our material, there were no differences in postoperative stroke despite a much higher risk of such complications in patients operated on using the off-pump technique.
The management of concurrent severe carotid and coronary disease is a subject of ongoing debate in the absence of randomized clinical trials. Severe carotid disease in the CABG population is often unilateral and asymptomatic and is not considered a risk factor for stroke or mortality. The problem becomes apparent in symptomatic or high-risk CAD patients such as those with LMD and contralateral carotid occlusion or bilateral severe stenosis. Priority is often given to coronary revascularization due to the severity of the angina, carrying however, a significant risk of a postoperative stroke of 10-12% [25] . This is in accordance with the current guidelines, which suggest targeting the most symptomatic territory first. Nevertheless, there are no clear guidelines on the surgical technique that should be used. In our material, patients with severe CAS and LMD were more frequently operated on using the off-pump technique rather than the on-pump. Differences in regard to MACCE between OPCAB and CABG were not found, but the low number of patients with CAS in each group may contribute to this finding. This study does not solve the problem of whether significant bilateral CAS and LMD should be treated synchronously or during a staged procedure. Nevertheless, we were able to demonstrate that choosing the off-pump approach in these high-risk patients is safe and effective and does not result in a higher incidence of neurological complications.
As the off-pump coronary revascularization technique continues to evolve, it strengthens its benefits across the most difficult patient populations. We strongly believe that the OPCAB technique may be safely applied to almost every patient undergoing coronary bypass grafting. This, together with more complete revascularization, should provide excellent long-term results.
The major limitation of the study comes from its retrospective, non-randomized nature. Consequently, a detailed patient followup could not be achieved and the composite outcome was limited to in-hospital observation. For the same reason, longterm results were based on death from all-causes instead of more appropriate cardiac-related causes. The type of surgical technique that was chosen was purely at the discretion of the operating surgeon, potentially introducing a significant bias. The degree of LMS was not a deciding criterion for the CABG or OPCAB group, however, such trend could be observed in the most diseased patients.
CONCLUSIONS
Off-pump coronary revascularization may offer a risk reduction of neurological complications in patients with a significant carotid artery disease and a history of previous stroke, but a larger study population is needed to support this thesis. The growing discrepancy in long-term survival should draw attention to a more complete revascularization in OPCAB patients.
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APPENDIX. CONFERENCE DISCUSSION
Dr D. Fullerton (Denver, CO, USA): I do have one disclosure to make and my disclosure is that in our programme we do not do off-pump surgery. We were the primary authors of the ROOBY study and, as soon as that was completed, we immediately stopped doing off-pump. So I don't mean to be provocative, but I must disclose that. And my bias was reinforced by Dr Pagano's talk yesterday at the postgraduate course.
You have a very large volume and you have excellent outcomes. And I must say that if there is ever a group of patients in whom off-pump coronary bypass surgery would seem to be the most appropriate strategy, it's the group that you've chosen to study. I had expected that you would tell us that the results were so much better in the off-pump group. Now, I acknowledge that they may have had a little more carotid disease, and there were a couple more women and that sort of thing. But given the large sample size, I was anticipating that you would show us that the off-pump group did a lot better, whereas in fact, they did exactly the same. So I'm curious, I think you've alluded to some of these things in your talk, but could you expand on that a little bit. Was it the fact that it's not a randomized trial that that doesn't come out? Are there other intangible aspects of this study that the reader of the manuscript wouldn't know? Or do you have any other insight into that?
Dr Zembala: I wanted to present our experience with the off-pump approach. As mentioned before, it was hard to compare those patients operated on in 2006 to those from 2010. The results were much different in terms of the number of grafts per patient. So we did better with time. Results from our other study comparing hybrid revascularization to off-pump-and these are data from 2011-reveal a mean of 2.9 grafts per patient. So it's clearly an experience-based approach. It is also an evolution going from 33% in 2006 to 75% in 2010, up to 85% of OPCABs in all patients with coronary artery disease in 2011. So it is truly hard to compare it now because most of the patients go to off-pump instead of to on-pump.
Dr D. Pagano (Birmingham, UK): Let me be provacative. It's taken you six years to learn how to place the same number of grafts that you would do on-pump and you have really not shown any benefit. Is it possible you've done any damage?
Dr Zembala: Well, it took us six years, but it's actually a different approach, because we have other surgeons who came to us with different experience. So it should not be regarded as just six years and the same team. It's a team approach and the team is expanding, surgeons are learning. So this is a different thing. As to the number of grafts, I think it's a matter of practice and experience. And the surgeons that we acquired from other centres were also experienced in off-pump technique and brought that completeness of revascularization with them.
Dr Pagano: I'm not quite sure that you answered my point about whether you may have caused adverse effects by having incompletely revascularized patients with off-pump for many years, up to when you got it right. What are your thoughts?
Dr Zembala: Well, that is a question that was brought up today about the completeness of revascularization. And I agree with Professor Taggart, it's difficult to say without FFR and just by looking at the angiograms. I do believe that as the FAME study showed us, it's not always the number that counts. We didn't see any postoperative MIs related to incomplete revascularization.
Dr R. Yadav (London, UK): I apologize if I missed it in your presentation, but what was the stroke rate in this clearly high-risk group of patients undergoing CABG with carotid disease, and how does that compare with patients without carotid disease in your experience?
Dr Zembala: It was pretty much similar to patients without carotid disease. There is one group in our study that somehow-and we should apologize for this-missed the screening for carotid disease. You can see on this slide the blue line showing the patients that were not screened for carotid artery disease and the red line showing the patients with the insignificant disease. Clearly the blue line has a worse survival rate than the patients without the disease. So that means that every patient who has diagnosed left main disease should have screening for carotid disease.
